S100A1 and metabolic dysfunction-associated steatotic liver disease: Although the functions of most S100 proteins are still poorly characterized, recent studies indicate that some have pleiotropic pathological functions in NAFLD/NASH fostering progression of these metabolic disorders toward severe stages and cancer development.